Echo starts new study of noninvasive glucose monitor
This article was originally published in Clinica
Executive Summary
Echo Therapeutics has started another pilot study of its noninvasive wireless Symphony transdermal continuous glucose monitoring system (tCGM). Results from the study, in 10 type 1 and type 2 diabetes patients, are expected in the third quarter of 2008. The primary purpose of the trial is to evaluate the Symphony system with the Franklin, Massachusetts firm's new Prelude skin preparation system. It will compare data obtained using Symphony with the gold-standard YSI (Yellow Springs Instrument) Glucose Analyzer and a widely-used "finger stick" glucometer. Echo is developing Symphony for use both at home and in hospital. In March, it reported encouraging results from another pilot study (see Clinica No 1299, p 26). Other noninvasive glucose tests include OrSense's ring-like monitor, NBM-200G, and GlucoLight's Sentris-100.
You may also be interested in...
What are the hottest innovations from Israel?
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
EuroPCR: St Jude and Philips talk up rival intravascular imaging techs
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
EuroPCR: Medtronic's drug-coated balloon keeps rising
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.